Lisata Therapeutics (LSTA) Assets Average (2016 - 2025)
Historic Assets Average for Lisata Therapeutics (LSTA) over the last 12 years, with Q3 2025 value amounting to $23.5 million.
- Lisata Therapeutics' Assets Average fell 4191.04% to $23.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.5 million, marking a year-over-year decrease of 4191.04%. This contributed to the annual value of $44.8 million for FY2024, which is N/A changed from last year.
- Per Lisata Therapeutics' latest filing, its Assets Average stood at $23.5 million for Q3 2025, which was down 4191.04% from $27.1 million recorded in Q2 2025.
- In the past 5 years, Lisata Therapeutics' Assets Average registered a high of $64.3 million during Q2 2023, and its lowest value of $23.5 million during Q3 2025.
- Over the past 3 years, Lisata Therapeutics' median Assets Average value was $45.4 million (recorded in 2024), while the average stood at $44.2 million.
- As far as peak fluctuations go, Lisata Therapeutics' Assets Average skyrocketed by 503.79% in 2024, and later tumbled by 4191.04% in 2025.
- Over the past 3 years, Lisata Therapeutics' Assets Average (Quarter) stood at $56.4 million in 2023, then tumbled by 35.1% to $36.6 million in 2024, then crashed by 35.9% to $23.5 million in 2025.
- Its last three reported values are $23.5 million in Q3 2025, $27.1 million for Q2 2025, and $32.0 million during Q1 2025.